Zelos Therapeutics
Zelos Therapeutics specializes in the development of innovative treatments for bone disorders and related indications in large, underserved markets. Led by an experienced team of biopharmaceutical executives and funded by leading health care investors, Zelos is advancing a portfolio of product opportunities in Phase 2 and 3 with significant commercial potential into late stage clinical trials. The company is pursuing programs linked by the common mechanism of stimulating bone formation – specifically parathyroid hormone (PTH) analogs - to provide therapeutic benefit in key indications including osteoporosis, orthopedics and renal bone disease.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
11 to 50
headcount range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Zelos Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- LS
Larry S. Potter
Assoc Dir Clinical Development · Research & Development
EmailPhone - GM
George Moonsammy
Vice President, Clinical Development · Research & Development
EmailPhone
Showing 2 of 3 verified contacts
Top roles at Zelos Therapeutics
3 distinct titles indexed · top 3 shown.
- 1assoc dir clinical development
- 1sr dir & head of regulatory affairs
- 1vice president, clinical development
Sign up to unlock all 3 contacts at Zelos Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Zelos Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.